Incretin mimetics vie for slice of type 2 diabetes market

Nat Biotechnol. 2007 Mar;25(3):263. doi: 10.1038/nbt0307-263. Epub 2007 Mar 1.
No abstract available

Publication types

  • News

MeSH terms

  • Adenosine Deaminase Inhibitors*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Dipeptidyl Peptidase 4
  • Dipeptidyl-Peptidase IV Inhibitors*
  • Drug Design*
  • Drug Industry* / economics
  • Drug Industry* / trends
  • Glucagon-Like Peptide 1 / agonists*
  • Glycoproteins / antagonists & inhibitors*
  • Humans

Substances

  • Adenosine Deaminase Inhibitors
  • Dipeptidyl-Peptidase IV Inhibitors
  • Glycoproteins
  • Glucagon-Like Peptide 1
  • DPP4 protein, human
  • Dipeptidyl Peptidase 4